Company Performance Metrics
EdiLabs develops a plant-based edible biologics platform for designing, manufacturing, and delivering orally available biologic therapies. The company focuses on transforming injectable, cold-chain dependent biologics into stable treatments that can be administered through edible formats. Its research integrates neuroscience, immunology, vaccine
development, and plant biotechnology to build preventive therapies and immunotherapies for conditions such as neurodegenerative diseases. EdiLabs works with drug development and preclinical partners to validate safety, dosing, and efficacy in established models. The platform is intended for use across multiple therapeutic areas where biologic drugs face bottlenecks in cost, manufacturing complexity, and patient access.
